Schusterman Family Investments

Schusterman Family Investments is a family office located in New York, New York. The firm focuses on managing a diverse portfolio by investing across various asset classes in both private and public markets. Through its strategic investment approach, Schusterman Family Investments aims to optimize financial growth while adhering to the values and objectives of the family it represents.

Sender Cohen

Chief Investment Officer

8 past transactions

Closed Loop Partners

Venture Round in 2025
Founded in 2014, Closed Loop Partners is a New York-based investment firm focused on driving sustainable profitability through early-stage investments. It operates across three key businesses: an investment group (Closed Loop Capital Management), an innovation center (Center for the Circular Economy), and an operating group (Closed Loop Builders). The firm aims to scale businesses that advance the transition to a circular economy, generating net-positive environmental and social outcomes.

Ratio Therapeutics

Series B in 2024
Ratio Therapeutics develops radiotherapeutics to treat various cancers. Its proprietary platforms, Trillium and Macropa, enable the imaging, discovery, and advancement of novel radiopharmaceuticals for epithelial-derived cancers like breast, pancreatic, lung, colon, and others.

SQream Technologies

Series C in 2023
SQream Technologies is a data analytics company offering a GPU-accelerated platform for big data. Its flagship SQream DB is a GPU-based columnar SQL database that emphasizes aggressive compression to reduce storage needs and delivers fast query performance. The company also offers xDR Repository, a solution for telecoms to store and analyze multi-source data and extract rapid value from a single platform. GenomeStack is a bioinformatics platform for data storage with real-time, correlated analytics. The technology relies on parallel computing using GPU hardware to boost analytics throughput across industries such as genome research, finance, cybersecurity, telecom, and Internet of Things. SQream collaborates with partners like DataDirect Networks, Telogic, and Moyo Business Advisory. Founded in 2010, the company is headquartered in New York with an additional office in London and an R&D center in Tel Aviv.

Soundtrack Your Brand

Venture Round in 2023
Soundtrack Your Brand offers a B2B music platform for small businesses. It enables them to legally create and play custom playlists in their venues through a monthly subscription service, providing access to a vast commercial catalog of songs.

Healthy.io

Series D in 2023
Healthy.io Ltd is a Tel Aviv-Yafo-based company founded in 2013 that specializes in home urinalysis kits for diagnosing diseases, urinary tract infections, and pregnancy complications. The company has developed an innovative product, Dip.io, which transforms a smartphone camera into a clinical-grade medical device for urine analysis. This product enables users to conduct urine tests by guiding them through the testing process, capturing images of test strips, and analyzing the results. The findings are automatically sent to the patient's electronic medical record for clinical follow-up. Healthy.io has expanded its offerings with an additional urinalysis test, ACR, designed for individuals with diabetes or high blood pressure to monitor kidney health. Furthermore, the company has ventured into chronic wound monitoring, providing tools to assess and manage chronic wounds effectively. Healthy.io aims to enhance patient care and facilitate remote health monitoring through its digital health technologies.

Healthy.io

Series D in 2023
Healthy.io Ltd is a Tel Aviv-Yafo-based company founded in 2013 that specializes in home urinalysis kits for diagnosing diseases, urinary tract infections, and pregnancy complications. The company has developed an innovative product, Dip.io, which transforms a smartphone camera into a clinical-grade medical device for urine analysis. This product enables users to conduct urine tests by guiding them through the testing process, capturing images of test strips, and analyzing the results. The findings are automatically sent to the patient's electronic medical record for clinical follow-up. Healthy.io has expanded its offerings with an additional urinalysis test, ACR, designed for individuals with diabetes or high blood pressure to monitor kidney health. Furthermore, the company has ventured into chronic wound monitoring, providing tools to assess and manage chronic wounds effectively. Healthy.io aims to enhance patient care and facilitate remote health monitoring through its digital health technologies.

Ratio Therapeutics

Series A in 2023
Ratio Therapeutics develops radiotherapeutics to treat various cancers. Its proprietary platforms, Trillium and Macropa, enable the imaging, discovery, and advancement of novel radiopharmaceuticals for epithelial-derived cancers like breast, pancreatic, lung, colon, and others.

VavaCars

Series C in 2022
VavaCars operates an online platform facilitating the buying and selling of used cars. It employs proprietary pricing and inspection technology to ensure transparency and convenience, making car ownership accessible and affordable. Additionally, VavaCars offers ancillary services like servicing and extended warranty for a comprehensive customer experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.